Elscint Clarifies Terms for Participation in Joint Venture for Television Channel Tender

Elscint Clarifies Terms for Participation in Joint Venture for
Television Channel Tender 


TEL AVIV, Israel, Dec. 13  /PRNewswire-FirstCall/ -- Elscint Limited (NYSE:
ELT) (the "Company") hereby clarifies that, further to its announcement of
November 30th, 2004 regarding the joint participation of the Company and Elbit
Medical Imaging ("EMI"), the controlling shareholder of the Company, in the
joint venture which intends to participate in the tender for a license for the
operation of Israel's Channel 2 television channel (the "Transaction"), the
participation of the Company in the Transaction was approved by the competent
decision making bodies of the Company in accordance with the provisions of
Section 1(4) of the Companies Regulations (Relief for Transactions with
Interested Parties) of 2000.

Accordingly, the Company's Audit Committee and Board of Directors have both
approved the Transaction and determined that the terms of the Transaction with
respect to the Company do not differ in any material respect from the terms of
the Transaction with respect to EMI, taking into consideration the Company's
and EMI's identical proportional share in the Transaction.

Elscint Limited has interests in hotels in Western Europe, in hotel development
projects principally in Western and Central Europe and in the "Arena"
commercial and entertainment center at Herzlia Marina in Israel.  More
information regarding the Company is available at: http://www.elscint.net/

This release contains certain forward-looking statements which involve known
and unknown risks, uncertainties or other factors not under the Company's
control which may cause actual results, performance or achievements of the
Company to be materially different from the results, performance or other
expectations implied by these forward-looking statements. These factors
include, but are not limited to, those detailed in the Company's periodic
filings with the Securities and Exchange Commission.

   For Further Information:

   Company Contact                          Investor Contact
   Marc Lavine, Adv.                        Rachel Levine
   Elscint Limited                          The Anne McBride Company
   + 972-3-608-6001                         + 212-983-1702  x207
                         

DATASOURCE: Elscint Limited



CONTACT:  Marc Lavine, Adv., Elscint Limited, [phone],

; Investors, Rachel Levine, The Anne McBride Company,

[phone] x207, , for Elscint Limited



Web site:  http://www.elscint.net/

Copyright